Relevant bibliographies by topics / Oral Antidiabetic

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Oral Antidiabetic'

Author: Grafiati
Published: 2 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Oral Antidiabetic.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Oral Antidiabetic"

1

Nana, Nurhasanah Rumanda, Khairunnisa, and Urip Harahap. "Potential Drug Interactions Of Oral Antidiabetic In Prescriptions Of Type 2 Diabetes Mellitus Patients At Kumpulan Pane Hospital." International Journal of Science, Technology & Management 2, no. 4 (2021): 1378–82. http://dx.doi.org/10.46729/ijstm.v2i4.278.

Full text
Abstract:

 
 
 
 Diabetes Mellitus is a disease that can cause complications of other diseases so that the treatment to be given becomes more and this has the potential for interactions between drugs that can affect the physiological condition of the patient. The aim of this study is to analyze the potential of oral antidiabetic interactions on prescription at Kumpulan Pane Hospital. Analysis of potential oral antidiabetic interactions on a prescription using quantitative research methods is retrospective descriptive. Prescriptions used are inpatient and outpatient prescriptions for
APA, Harvard, Vancouver, ISO, and other styles
2

Lukito, Johan Indra. "Antidiabetik Oral Kombinasi Penghambat DPP-4 dan Penghambat SGLT-2." Cermin Dunia Kedokteran 48, no. 12 (2021): 692–95. http://dx.doi.org/10.55175/cdk.v48i12.157.

Full text
Abstract:
Dalam tatalaksana diabetes melitus tipe 2, terapi kombinasi dua obat antidiabetik disarankan jika dengan monoterapi gagal mencapai target kontrol glikemik. Pemilihan jenis obat antidiabetik tergantung kondisi pasien dan profil obat. Kombinasi obat antidiabetik oral golongan penghambat DPP-4 (dipeptidyl peptidase-4) dan penghambat SGLT-2 (sodium-glucose cotransporter type 2) dapat menjadi salah satu pilihan.
 Combination of two antidiabetic drugs is recommended in the management of type 2 diabetes mellitus if monotherapy fails to achieve glycemic control targets. Choice of antidiabetic dru
APA, Harvard, Vancouver, ISO, and other styles
3

Lukito, Johan Indra. "Antidiabetik Oral Kombinasi Penghambat DPP-4 dan Penghambat SGLT-2." Cermin Dunia Kedokteran 48, no. 12 (2021): 692. http://dx.doi.org/10.55175/cdk.v48i12.1572.

Full text
Abstract:
<p>Dalam tatalaksana diabetes melitus tipe 2, terapi kombinasi dua obat antidiabetik disarankan jika dengan monoterapi gagal mencapai target kontrol glikemik. Pemilihan jenis obat antidiabetik tergantung kondisi pasien dan profil obat. Kombinasi obat antidiabetik oral golongan penghambat DPP-4 (dipeptidyl peptidase-4) dan penghambat SGLT-2 (sodium-glucose cotransporter type 2) dapat menjadi salah satu pilihan.</p><p>Combination of two antidiabetic drugs is recommended in the management of type 2 diabetes mellitus if monotherapy fails to achieve glycemic control targets. Choic
APA, Harvard, Vancouver, ISO, and other styles
4

Dascultu, Dana Adriana, Elena Madalina Petran, and Coriolan Emil Ulmeanu. "Epidemiology in oral antidiabetic poisoning in children and adolescents – a four-year study in a pediatric poison centre." Romanian Journal of Pediatrics 70, no. 1 (2021): 53–57. http://dx.doi.org/10.37897/rjp.2021.1.10.

Full text
Abstract:
Oral antidiabetics have become a common etiology associated with acute poisoning in children. The study shall carry out an analysis of the demographic characteristics, circumstantial characteristics and clinical profile associated with oral antidiabetic poisoning. An observational, descriptive and retrospective study was carried out over a period of 4 years including children confirmed with the diagnosis of acute poisoning with oral antidiabetics. In the study group, there is a prevalence of voluntary acute poisoning in female patients in the 15 to 18 year age group. bIn the group study biguan
APA, Harvard, Vancouver, ISO, and other styles
5

Lebovitz, Harold E. "Oral Antidiabetic Agents." Drugs 44, Supplement 3 (1992): 21–28. http://dx.doi.org/10.2165/00003495-199200443-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Scheen, J., and Pierre J. Lef??bvre. "Oral Antidiabetic Agents." Drugs 55, no. 2 (1998): 225–36. http://dx.doi.org/10.2165/00003495-199855020-00004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Krentz, Andrew J., and Clifford J. Bailey. "Oral Antidiabetic Agents." Drugs 65, no. 3 (2005): 385–411. http://dx.doi.org/10.2165/00003495-200565030-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Melander, A., L. O. Almér, G. Sartor, B. Scherstén, and E. Wåhlin-Boll. "Oral Antidiabetic Therapy." Acta Medica Scandinavica 210, S656 (2009): 55–57. http://dx.doi.org/10.1111/j.0954-6820.1982.tb07704.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hidayati, Nur Rahmi, Dyah Aryani Perwitasari, Imaniar Noor Faridah, and Rinto Susilo. "Effect of Gene Polymorphisms on Oral Antidiabetic Drug Response in Patients With Type 2 Diabetes Mellitus." Sciences of Pharmacy 4, no. 2 (2025): 72–80. https://doi.org/10.58920/sciphar0402321.

Full text
Abstract:
Diabetes mellitus is currently one of the global health threats. The prevalence and incidence of this disease continue to increase, both in industrialised and developing countries, including Indonesia. There are different types of DM marker gene polymorphisms in each racial group. These genetic variations contribute to the response of oral antidiabetic drugs. This article aims to conduct a narrative review of the influence of gene polymorphisms on oral antidiabetic drug response in patients with type 2 diabetes mellitus. Article searches were conducted in PubMed, Scopus, Google Scholar, and Wi
APA, Harvard, Vancouver, ISO, and other styles
10

Bintang, Sri. "EVALUASI ORAL ANTIDIABETIK PADA PASIEN DIABETES MELITUS TIPE 2 DI RSUD "X" LAMONGAN." Journal of Herbal, Clinical and Pharmaceutical Science (HERCLIPS) 2, no. 1 (2021): 1. http://dx.doi.org/10.30587/herclips.v2i1.2188.

Full text
Abstract:
Diabetes Mellitus Type 2 is a metabolic disorder characterized by an increase in blood sugar due to decreased insulin secretion by pancreatic beta cells and or insulin function disorders (insulin resistance). This study aims to evaluate oral antidiabetics in patients with type 2 diabetes mellitus at the Regional General Hospital dr. Soegiri Lamongan. This research design is descriptive with a population of all type 2 diabetes mellitus patients from July to August 2019 using a total sampling technique. The number of samples in this study were 64 patients. The results showed that the most prescr
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Oral Antidiabetic"

1

Stankūnaitė, Eglė. "Pharmacoepidemiological study and costs analysis of oral antidiabetic drugs and insulins in Lithuania on 2006-2009 year." Master's thesis, Lithuanian Academic Libraries Network (LABT), 2010. http://vddb.laba.lt/obj/LT-eLABa-0001:E.02~2010~D_20100621_092504-76708.

Full text
Abstract:
Objective: To perform pharmacoepidemiological study of the use of oral antidiabetic drugs and insulins in Lithuania on 2006-2009 year and cost-minimization and reference price analysis enabling more rational use of financial resources of national health system. Material ans methods: The search for all literature relating to pharmacokinetic and pharmacodynamic chareacteristics of drugs for diabetes mellitus was done in MEDLINE database. The data on total sales of oral antidiabetic drugs and insulins in Lithuania over a four-year period (2006-2009) were obtained from Softdent, Lithuania data ba
APA, Harvard, Vancouver, ISO, and other styles
2

Davis-Ajami, Mary Lynn. "The association between joblessness and adult working age diabetic oral antidiabetic medication adherence and health services utilization." The Ohio State University, 2010. http://rave.ohiolink.edu/etdc/view?acc_num=osu1282067521.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Steyn, Rianda. "The usage of antidiabetic drugs : a managed care approach / Rianda Steyn." Thesis, North-West University, 2005. http://hdl.handle.net/10394/1029.

Full text
Abstract:
"Diabetes mellitus" refers to a spectrum of conditions, which all present with hyperglycaemia as a common medical finding. Diabetes was once thought of as a single disease, but according to Setter et a/. (2000:378), it includes a heterogeneous group of disorders that are secondary to various genetic predispositions and precipitating factors. Type 1 diabetes mellitus (DM) accounts for 10 to 15% of all cases of diabetes mellitus and is clinically characterised by hyperglycaemia and a propensity to diabetic keto-acidosis. Its control requires chronic insulin treatment. Although it may occur at an
APA, Harvard, Vancouver, ISO, and other styles
4

Shenolikar, Rahul. "Racial differences in oral antidiabetic medication adherence, healthcare utilization and costs associated with type 2 diabetes in medicaid enrollees." The Ohio State University, 2006. http://rave.ohiolink.edu/etdc/view?acc_num=osu1156948396.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Niemi, Mikko. "Effects of induction and inhibition of cytochrome P-450 enzymes on the pharmacokinetics and pharmacodynamics of oral antidiabetic drugs." Helsinki : University of Helsinki, 2001. http://ethesis.helsinki.fi/julkaisut/laa/kliin/vk/niemi/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Heitzmann, Thomas. "Untersuchungen zur Pharmakokinetik der Alpha-aktivierten Carbonsäuren (-)-BM 13.1074, BM 17.0505, BM 13.1196, BM 13.1188 und BM 13.1180 sowie der Thiazolidindione CS-045, BM 13.1244,BM 13.1246, BM 13.1215 und BM 50.1050 als potentielle orale Antidiabetika /." [S.l. : s.n.], 1994. http://www.gbv.de/dms/bs/toc/156825465.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lu, I.-Chia, and 魯怡佳. "Decomposition of factors influencing expenditure variation of oral antidiabetic drugs." Thesis, 2018. http://ndltd.ncl.edu.tw/handle/8qnety.

Full text
Abstract:
碩士<br>國立臺灣大學<br>健康政策與管理研究所<br>106<br>Objective: This study aimed to describe the trends in the use and spending on oral antidiabetic drugs and to explore factors that influenced expenditure variation in Taiwan during 2009-2013. Methods: Data were extracted from National Health Insurance Research Database (NHIRD). Using a non-stochastic, index-theoretical method, changes in expenditures on oral antidiabetic drugs were decomposed into 6 cost-impact determinants: prescription volume, prescription size, price, generic use, therapeutic mix, and drug mix. These 6 determinants could be classified int
APA, Harvard, Vancouver, ISO, and other styles
8

Silva, Susana Melissa Ribeiro da. "Abdominal Aortic Aneurysm: a review on the role of oral antidiabetic drugs." Master's thesis, 2020. https://hdl.handle.net/10216/128689.

Full text
Abstract:
Introdução: Uma relação negativa paradoxal entre a Diabetes Mellitus e a prevalência e crescimento de um Aneurisma da Aorta Abdominal está estabelecida. Todavia, ainda não foi possível determinar se esta proteção é conferida pela Diabetes Mellitus ou pelo tratamento dirigido à Diabetes. O objetivo deste manuscrito é rever a associação entre antidiabéticos orais e a incidência e crescimento dos AAA. Métodos: Uma pesquisa foi conduzida nas bases de dados Pubmed e Scopus até dezembro de 2019 por forma a identificar publicações que reportem a associação entre antidiabéticos orais (biguanidas/metfo
APA, Harvard, Vancouver, ISO, and other styles
9

Silva, Susana Melissa Ribeiro da. "Abdominal Aortic Aneurysm: a review on the role of oral antidiabetic drugs." Dissertação, 2020. https://hdl.handle.net/10216/128689.

Full text
Abstract:
Introdução: Uma relação negativa paradoxal entre a Diabetes Mellitus e a prevalência e crescimento de um Aneurisma da Aorta Abdominal está estabelecida. Todavia, ainda não foi possível determinar se esta proteção é conferida pela Diabetes Mellitus ou pelo tratamento dirigido à Diabetes. O objetivo deste manuscrito é rever a associação entre antidiabéticos orais e a incidência e crescimento dos AAA. Métodos: Uma pesquisa foi conduzida nas bases de dados Pubmed e Scopus até dezembro de 2019 por forma a identificar publicações que reportem a associação entre antidiabéticos orais (biguanidas/metfo
APA, Harvard, Vancouver, ISO, and other styles
10

Adeyemi, Ayoade Olayemi. "Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes." Thesis, 2011. http://hdl.handle.net/2152/ETD-UT-2011-05-2759.

Full text
Abstract:
The present study involved the analyses of the Texas Medicaid prescription claims data. The population studied was made up of subjects between 10 and 18 years who had at least 2 prescriptions of the same oral antidiabetic (OAD) medication from January 1, 2006 through December 31, 2009. Twelve months’ data for each subject were analyzed. The main aim of the study was to describe OAD medication use patterns in the study population, assess trends in Medication Possession Ratio (MPR) and persistence in the study population and determine the relationship between age and MPR and between age and pers
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Oral Antidiabetic"

1

Kuhlmann, Jochen, and Walter Puls, eds. Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

J, Ahr H., Kuhlmann J, and Puls Walter, eds. Oral antidiabetics. Springer, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Møller, J. Toxic oral antidiabetics in relation to cardiovascular disease. ecomed, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

(Editor), Jochen Kuhlmann, and W. Puls (Editor), eds. Oral Antidiabetis. Springer, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kuhlmann, Jochen, and Walter Puls. Oral Antidiabetics. Springer London, Limited, 2013.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Aumüller, W. Oral wirksame Antidiabetika. Brand: Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pengaruh diit, latihan fisik, dan pemberian obat antidiabetik oral terhadap triad lipid darah penderita baru diabetes mellitus tipe-II laki-laki: Laporan penelitian. Departemen Pendidikan dan Kebudayaan R.I., Direktorat Jenderal Pendidikan Tinggi, Universitas Sumatera Utara, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles

Book chapters on the topic "Oral Antidiabetic"

1

Bailey, Clifford J., and Andrew J. Krentz. "Oral Antidiabetic Agents." In Textbook of Diabetes. Wiley-Blackwell, 2010. http://dx.doi.org/10.1002/9781444324808.ch29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Bischoff, H., and H. E. Lebovitz. "Oral Antidiabetic Drugs in Research and Development." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Bhandari, Prasan. "Insulin and oral antidiabetic agents." In Pharmacology Mind Maps for Medical Students and Allied Health Professionals. CRC Press, 2019. http://dx.doi.org/10.1201/9780429023859-53.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Lotz, N., W. Bachmann, H. Mehnert, and E. Standi. "Combining insulin with oral antidiabetic agents (including problems of secondary failure)." In Pharmacology of Diabetes, edited by C. E. Mogensen and E. Standl. De Gruyter, 1990. http://dx.doi.org/10.1515/9783110850321-010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Altmann, J., A. W. Kornhuber, and H. H. Kornhuber. "Riskfactors of „Normal“ Alcohol Consumption, Oral Antidiabetic Drugs, and Treatment of Stroke." In Verhandlungen der Deutschen Gesellschaft für Neurologie. Springer Berlin Heidelberg, 1987. http://dx.doi.org/10.1007/978-3-642-83201-7_203.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kuhlmann, J. "Introduction." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Prugnard, E., and M. Noel. "Chemistry and Structure-Activity Relationships of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Prugnard, E., and M. Noel. "Physicochemical Properties and Analytical Methods of Determination of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wiernsperger, N. F. "Preclinical Pharmacology of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schmidt, F., F. Hartig, W. Rebel, and P. Ochlich. "Toxicology of Biguanides." In Oral Antidiabetics. Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-662-09127-2_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Oral Antidiabetic"

1

Selvaag, Edgar, Anita B. Petersen, Robert Gniadecki, Tine Thorn, and Hans Christian Wulf. "Antidiabetics and diuretics show phototoxicity in HaCaT cells." In European Conference on Biomedical Optics. Optica Publishing Group, 2001. http://dx.doi.org/10.1364/ecbo.2001.4433_158.

Full text
Abstract:
The antidiabetics tolbutamide, glibenclamide, and glipizide, and the diuretics bendroflumethiazide, butizide, furosemide, hydrochlorothiazide, and trichlormethiazide were investigated for potential phototoxicity in the HaCaT cell line. The cells were incubated with the drugs and then exposed to UVA1 irradiation. The effects of the antioxidants L-ascorbic acid, and α-tocopherol on oxidative DNA damage were assessed. Bendroflumethiazide, furosemide, hydrochlorothiazide, trichlormethiazide, or tolbutamide induced dose-dependent phototoxicity. Cells incubated with bendroflumethiazide, tolbutamide,
APA, Harvard, Vancouver, ISO, and other styles
2

Dwita, Lusi Putri, Vivi Anggia та Tri Dewi Prasetyatuti. "Artocarpus altilis Leaves Activity in Inhibiting α-Amylase Enzyme as Oral Antidiabetic Drug Candidate". У Bromo Conference, Symposium on Natural Products and Biodiversity. SCITEPRESS - Science and Technology Publications, 2018. http://dx.doi.org/10.5220/0008359301680173.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Sophie Holdt-Caspersen, Nynne, Stine Hangaard Casper, Peter Vestergaard, Claus Dethlefsen, and Morten Hasselstrøm Jensen. "The Adherence to Oral Second Line Antidiabetic Medication in People with Type 2 Diabetes - A Protocol for a Systematic Review." In 18th Scandinavian Conference on Health Informatics. Linköping University Electronic Press, 2022. http://dx.doi.org/10.3384/ecp187035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Ibrahim, Khadega, Chiara Cugno, and Md Mizanur Rahman. "Conjugated Linoleic Acid (CLA) co-treatment alleviates antidiabetic drug, rosiglitazone associated deterioration of bone remodeling." In Qatar University Annual Research Forum & Exhibition. Qatar University Press, 2021. http://dx.doi.org/10.29117/quarfe.2021.0148.

Full text
Abstract:
Diabetes mellitus (DM) is a chronic metabolic disease characterized by hyperglycemia due to decreased insulin secretion, defective action or both. The rosiglitazone (RSG) is one of the oral antidiabetic drug used in type 2 (T2) DM and has a unique insulin-sensitizing capacity. However, RSG has a negative side effect on the bone as it stimulates the differentiation of bone marrow-mesenchymal stromal cells (BM-MSCs) into adipocytes at the expense of osteoblasts in the bone marrow microenvironment, disturbing the normal balance of bone remodeling and causing BM adiposity. On the other hand, the t
APA, Harvard, Vancouver, ISO, and other styles
5

Grigoli, Marina, Danielle de Oliveira, Paloma Zanarelli, Patrícia Manzine, and Márcia Cominetti. "INSULIN PATHWAY PROTEINS ARE ALTERED IN PATIENTS WITH CONCOMITANT ALZHEIMER’S DISEASE AND DIABETES MELLITUS." In XIII Meeting of Researchers on Alzheimer's Disease and Related Disorders. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1980-5764.rpda001.

Full text
Abstract:
Background: Alterations in the insulin pathway proteins have been associated with brain disorders, including Alzheimer’s disease (AD). Objectives: To investigate the peripheral levels of the insulin pathway proteins between cognitively and metabolically preserved participants, patients with DM2, AD and those with the concomitant presence of AD and DM2. Methods: The study was approved by the UFSCar’s ethics committee (CAAE: 31634720.9.0000.5504). Patients were diagnosed with AD using the criteria of the National Institute on Aging/Alzheimer’s Association (NIA/AA). DM2 was defined as self-report
APA, Harvard, Vancouver, ISO, and other styles
6

Hallur, Raghavendra, Anushka Sahay, Sarwan Bradosty, and Faiyaz Shaikh. "Inhibitory Effects of a Specific Phytochemical Combination on Carbohydrate Metabolism, Lipid Digestion, and Free Radicals: An in Vitro Study." In 5th International Conference on Biomedical and Health Sciences. Cihan University-Erbil, 2024. http://dx.doi.org/10.24086/biohs2024/paper.1247.

Full text
Abstract:
Abstract—Context: Diabetes, characterized by insulin insufficiency/resistance and oxidative stress, is a global health concern. Traditional plant combinations offer potential as oral diabetes therapy due to their multifaceted pharmacological properties. Aims: This study evaluated the antidiabetic, antilipidemic, and antioxidant potential of a phytochemical combination comprising Salacia extracts (Salacia chinensis and Salacia oblonga), Curcumin, and Piperine. Settings and Design: In vitro experiments assessed the inhibitory activity of the phytochemical combination on key enzymes related to ca
APA, Harvard, Vancouver, ISO, and other styles
7

Selvaag, Edgar, Helle Anholt, Johan Moan, and Per Thune. "Phototoxicity to sulphonamide-derived oral antidiabetics and diuretics: comparative in-vitro and in-vivo investigations." In BiOS Europe '97, edited by Kristian Berg, Benjamin Ehrenberg, Zvi Malik, Johan Moan, and Abraham Katzir. SPIE, 1997. http://dx.doi.org/10.1117/12.297815.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Fitriani, Rina, Muhammad Amir Masruhim, and Dewi Rahmawati. "ANALISA TINGKAT KEPATUHAN PENGGUNAAN TERAPI OBAT ORAL ANTIDIABETIK (OAD) PADA PASIEN DIABETES MELLITUS DI INSTALASI RSUD. A.W SJAHRANIE." In Mulawarman Pharmaceuticals Conferences. Fakultas Farmasi, Universitas Mulawarman, Samarinda, 2015. http://dx.doi.org/10.25026/mpc.v2i1.40.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Pfohl, M., S. Pscherer, A. Fritsche, H. Anderten, K. Pegelow, and J. Seufert. "Wirksamkeit von Insulin glargin 300 E/ml (Gla-300) bei Neueinstellung von Typ-2-Diabetespatienten auf eine basalunterstützte orale Therapie (BOT) nach Versagen der oralen Antidiabetika- (OAD-)Therapie – 6-Monats-Ergebnisse der Toujeo-1-Studie." In Diabetes Kongress 2018 – 53. Jahrestagung der DDG. Georg Thieme Verlag KG, 2018. http://dx.doi.org/10.1055/s-0038-1641916.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Oral Antidiabetic"

1

Yibchok-anun, Sirinthorn, Wijit Banlunara, and Sirichai Adisakwattana. Antidiabetic effects, mechanisms of of p-methoxy-trans-cinnamic acid. Faculty of Veterinary Science, Chulalongkorn University, 2008. https://doi.org/10.58837/chula.res.2008.81.

Full text
Abstract:
p-Methoxycinnamic acid (p-MCA) is a cinnamic acid derivative that shows various pharmacologic actions such as neuroprotective and hepatoprotective activities. To examine the insulinotropic activity of p-MCA, the perfused rat pancreas and a pancreatic β-cell line, INS-1 were used in the studies. P-MCA increased insulin secretion from the perfused rat pancreas and INS-1 cells in a concentration-dependent manner. In addition, p-MCA increased intracellular Ca²⁺ concentration ([Ca²⁺]i) in INS-1 cells. The p-MCA-induced insulin secretion and rise in [Ca²⁺]i were markedly inhibited in the absence of
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Oral Antidiabetic' for particular source types:
Journal articles Dissertations / Theses
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography